Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
20h
Zacks Investment Research on MSNNew Thrombectomy Product Launches Support PEN Stock Amid Macro IssuesPenumbra PEN is gaining traction in the U.S. and international markets on strong customer uptake of its Lightning Bolt and Flash lines. Yet, unfavorable currency movements and rising expenses are ...
Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results